Pictet Asset Management (UK)’s Ligand Pharmaceuticals LGND Stock Holding History

Pictet Asset Management (UK)’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,244	Closed	-$213K	–	1814
2021 Q1	$213K	Buy	+2,244	New	+$212K	﹤0.01%	1648
2017 Q3	–	Sell	-61,235	Closed	-$4.14M	–	896
2017 Q2	$4.14M	Buy	61,235 +4,809	+9%	+$336K	0.01%	658
2017 Q1	$3.73M	Hold	56,426	–	–	0.01%	671
2016 Q4	$3.58M	Buy	+56,426	New	+$3.56M	0.01%	643

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management (UK)'s LGND Position: Q2 2021 in Review

Pictet Asset Management (UK) sold out of Ligand Pharmaceuticals (LGND) in Q2 2021, closing a stake of 2,244 shares — an estimated $213K sold.

Pictet Asset Management (UK) first reported a position in LGND in Q4 2016 and held it in 4 quarters. The position peaked at $4.14M in Q2 2017. 212 funds tracked by Wall St. Rank hold LGND as of Q2 2021.

Pictet Asset Management (UK) reported no remaining Ligand Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Pictet Asset Management (UK) sold 2,244 Ligand Pharmaceuticals shares in Q2 2021, an estimated $213K.
Pictet Asset Management (UK) first reported a position in Ligand Pharmaceuticals in Q4 2016 and held it in 4 quarters.
Pictet Asset Management (UK)'s Ligand Pharmaceuticals position peaked at $4.14M in Q2 2017.
212 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.